A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

Proprietary Information - Exploratory (Non-confirmatory) Trial

Status

Terminated

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00282763

Enrollment

Registered

2006-01-27

Start date

2005-12-31

Completion date

2006-08-31

Last updated

2015-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuralgia, Postherpetic

Brief summary

The purpose of this Study is to test the Safety and Effectiveness of MK0686 in relieving neuropathic (chronic) pain as experienced by patients with Postherpetic Neuralgia (Also Know as PHN or Post Shingles Pain). This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Interventions

DRUGMK0686

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Diagnosis of postherpetic neuralgia with pain having lasted at least 6 months * Able to complete study questionnaires, patient diary, and comply with daily study medication * Patient is not satisfied with current treatment for pain control

Exclusion criteria

* Pregnant or nursing female * History of evidence of a condition that in the opinion of the investigator, may interfere with the study results (e.g., diabetic neuropathy of fibromyalgia) or pose undue risk to undergo the course of medication required by the study (e.g., unstable heart disease, morbid obesity, kidney or liver disease)

Design outcomes

Primary

Measure	Time frame
proprietary information - exploratory (non-confirmatory) trial	—

Secondary

Measure	Time frame
proprietary information - exploratory (non-confirmatory) trial	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026